To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma

NCT01568762 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: VAK694
DRUG: VAK694 placebo
DRUG: QAX576
DRUG: QAX576 placebo

Sponsor

Novartis Pharmaceuticals